EA Bridgeway Blue Chip ETF(BBLU.US)

Company Encyclopedia
View More
name
EA Bridgeway Blue Chip ETF
BBLU.US
News
View More

BUZZ-Chipmakers set to log 2025 gains as AI rally persists despite bubble fears

Chipmakers are projected to see significant gains in 2025, driven by ongoing investments in AI despite bubble concerns. The Philadelphia Semiconductor Index is expected to close over 43% higher, marking its third consecutive year of gains. Nvidia is on track for a ~40% increase, while Broadcom anticipates a 50% rise. AMD could close ~80% higher, and Intel is set for an 86% increase. Micron may rise nearly 250% due to AI demand, and Qualcomm is expected to see a 13% rise. Analysts from Jefferies note that AI remains a strong focus for investors.

Reuters·
US
QCOM
+0.13%
US
AMD
-0.13%
US
INTC
+1.69%
Reuters·
US
QCOM
+0.13%
US
AMD
-0.13%
US
INTC
+1.69%

These stocks are moving the most today: Nvidia, Tesla, Hecla, Newmont, Nike, Vanda, Western Digital, and more

Nvidia shares edge higher on reports of strong interest in the chip maker’s hardware from Chinese customers, while Newmont and Hecla Mining decline as precious metals prices tumble.

MSN·
US
NVDA
-0.36%
MSN·
US
NVDA
-0.36%

U.S. Virgin Islands Sues Meta Platforms over Child Safety Concerns, Profiting from Scam Ads

The U.S. Virgin Islands' Attorney General has sued Meta Platforms, alleging the company failed to ensure child safety on its apps and profited from scam advertisements. The lawsuit claims that 10% of Meta's projected $16 billion revenue for 2024 may come from ads for scams and illegal products. Following media reports, U.S. senators have called for investigations by the SEC and FTC. Meta disputes the allegations, citing a 50% reduction in scam reports on its platforms. The case highlights growing scrutiny of social media policies regarding children's safety.

Tip Ranks·
US
META
+1.10%
Tip Ranks·
US
META
+1.10%

BUZZ-Weight-loss drug frenzy powers Lilly for ninth straight annual rise

Eli Lilly's shares have surged nearly 40% this year, marking its ninth consecutive annual rise, and the company recently joined the trillion-dollar club. In contrast, rival Novo Nordisk's stock has dropped 40% this year. Investors are keen on Lilly's upcoming oral GLP-1 drug, orforglipron, expected to launch in 2026. Despite potential price adjustments, sales for Lilly are projected to grow by 20% to $76.8 billion in 2026, driven by diabetes drug Mounjaro and obesity treatment Zepbound.

Reuters·
US
LLY
+0.09%
Reuters·
US
LLY
+0.09%

How $160 million worth of export-controlled Nvidia chips were allegedly smuggled into China

Federal prosecutors in Texas revealed a smuggling network, dubbed "Operation Gatekeeper," that allegedly exported $160 million worth of Nvidia GPUs to China, violating U.S. export control laws. The operation involved falsifying shipping documents and using undercover agents to infiltrate a New Jersey warehouse. The investigation highlights the ongoing struggle between the U.S. and China for access to advanced AI chips. Despite Nvidia's efforts to prevent illegal exports, the demand for their technology in China remains high. The case has led to multiple arrests and a guilty plea related to the smuggling activities.

CNBC·
US
NVDA
-0.36%
US
NVDL
-0.80%
HK
07788
-0.30%
CNBC·
US
NVDA
-0.36%
US
NVDL
-0.80%
HK
07788
-0.30%
© 2025 Longbridge｜Disclaimer